FOSTER CITY, CALIFORNIA, UNITED STATES, October 29, 2018 /EINPresswire.com/ — Scientists from MedGenome, Bangalore, India in collaboration with oncologists from Tata Memorial Hospital, Mumbai, India and scientists at Genentech, a member of the Roche Group, South San Francisco, Calif., USA, report in Cancer Cell the identification of a treatable mutation linked to lung cancer. A […]
MedGenome’s recent paper “A cancer vaccine approach for personalized treatment of Lynch Syndrome” is published in Scientific Reports FOSTER CITY, CALIFORNIA, UNITED STATES, August 21, 2018 /EINPresswire.com/ — The published study examines the feasibility of treating Lynch syndrome using a personalized cancer vaccine approach by identifying potential immunogenic tumor specific alterations. Lynch syndrome is a
MedGenome presented a poster on its study of potential cancer vaccines for Lynch Syndrome patients SAN FRANCISCO, CALIFORNIA, UNITED STATES, February 24, 2018 /EINPresswire.com/ — Attendees at the 2018 Molecular Medicine Tri-Conference heard MedGenome, a global leader in genomics research and a partner to pharma/biotech companies and academic research institutions conducting complex disease biomarker-identification projects,
FOSTER CITY, Calif., Jan. 31, 2018 /PRNewswire/ — MedGenome has expanded its sequencing capacity at its Foster City, Calif., headquarters laboratory, adding HiSeqX and NovaSeq 6000 platforms to meet the rising demands for Next Generation Sequencing (NGS) in research and clinical settings. The new additions increase MedGenome’s data-generation capability by a factor of five. Additionally,
